Inlay

ProfilePosts

#EACVI2025 Excited to be here in Vienna alongside my colleagues for some of the exciting science in multimodality imaging. @annakatebarton.bsky.social

If you work at the Washington Post, now is the time to resign. You’re a part of this now.

Delighted w our Cunsensus Document on preventing heart failure in cardiac-oncology at #EJHF @escardio.bsky.social onlinelibrary.wiley.com/doi/10.1002/... Potential importance of SGLTi noted academic.oup.com/eurjpc/advan... With great colleagues who R not on Blue Sky-repost to attract them here!

Mar 3, 2025

11mo

6mo

Impact of Smoking on Coronary Volume–to–Myocardial Mass Ratio Myocardial Mass Drives Unfavorable Changes in Smokers’ Hearts #CardioSky #RadSky pubs.rsna.org/doi/10.1148/... @rsnasky.bsky.social @katehanneman.bsky.social @annakatebarton.bsky.social @chriskramermd.bsky.social @mugander.bsky.social

Million Veteran Program: dietary cholesterol intake was linearly associated with greater risk of MI #CardioSky #MedSky #JAHA www.ahajournals.org/doi/10.1161/... @erinmichos.bsky.social @michaeldshapiro.bsky.social @drmarthagulati.bsky.social @psatishmd.bsky.social @drlipid.bsky.social

Feb 10, 2025

Feb 17, 2025

10mo

Always exciting to see new HF agents in development! I enjoyed reading this interesting study using porcine model of HF with some promising outcomes for MiR-132. Available now in @escardio.bsky.social journal EHJ-IMP: academic.oup.com/ehjimp/artic...

Conduction system pacing: promoting the physiology to prevent HF Background and Clinical perspectives of HBP and LBBP area in HF link.springer.com/article/10.1... #HF #CardioSky #CardioEd @cardioobdoc.bsky.social @drrajivsankar.bsky.social @annakatebarton.bsky.social @vietheartpa.bsky.social

Apr 5, 2025

Bashaer Gheyath MD FACC

Zach D Roberts

Parham Eshtehardi MD

Vass Vassiliou

Parham Eshtehardi MD

Henry Han

Mar 28, 2025

Worth a reminder 👆 (& a repost!) jamanetwork.com/journals/jam... @drmarthagulati.bsky.social @gbiondizoccai.bsky.social @hancardiomd.bsky.social @anastasiasmihaili.bsky.social @annakatebarton.bsky.social @cardioobdoc.bsky.social @benoyshah.bsky.social @drrajivsankar.bsky.social

Am doing an informal poll- will bluesky or X give most reposts for our last paper? @benoyshah.bsky.social @drmarthagulati.bsky.social @erinmichos.bsky.social @jgrapsa.bsky.social @anastasiasmihaili.bsky.social @annakatebarton.bsky.social @tharusha.bsky.social academic.oup.com/eurjpc/advan...

Mar 7, 2025

Anna Kate Barton

Vass Vassiliou

Two years ago we published our seminal meta-analysis on risk factors of long covid- cited 548 times & the WHO guidelines @JAMA.com jamanetwork.com/journals/jam... Females, elderly, smokers, obese, comorbidities & hospitalisation had higher risk One thing protected from long covid: vaccination

Mar 28, 2025

Vass Vassiliou

academic.oup.com

AbstractAims. Cardiac miR-132 has been proposed as a target for heart failure (HF) therapy. CDR132L, a rationally designed synthetic oligonucleotide inhibi

Vass Vassiliou

MiR-132 inhibition improves myocardial strain in a large animal model of chronic left ventricular adverse remodelling

This systematic review and meta-analysis evaluates the findings of 41 studies with a total of 860 783 patients to identify risk factors associated with post−COVID-19 condition.

Risk Factors for Post−COVID-19 Condition

jamanetwork.com

AbstractAims. Sodium–glucose cotransporter-2 inhibitors (SGLT2i) are recognized for their cardiovascular benefits. This systematic review and meta-analysis

academic.oup.com

Impact of sodium–glucose cotransporter-2 inhibitors on heart failure outcomes in cancer patients and survivors: a systematic review and meta-analysis

Our latest paper on EJPC @escardio.bsky.social on use of SGLT2i in cancer patients… Reduces heart failure hospitalisation by 50%! And mortality! Breaat ca pts benefit most Read it at: academic.oup.com/eurjpc/advan... @drmarthagulati.bsky.social @purviparwani.bsky.social @mmamas1973.bsky.social

Mar 6, 2025

Vass Vassiliou